Biodexa Pharmaceuticals
Stock Forecast, Prediction & Price Target
Biodexa Pharmaceuticals Financial Estimates
Biodexa Pharmaceuticals Revenue Estimates
Biodexa Pharmaceuticals EBITDA Estimates
Biodexa Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | |
Revenue
% change YoY
| $578K N/A | $699K 20.93% | $381K -45.49% | Avg: $13.05K Low: $13.05K High: $13.05K avg. -96.57% | Avg: $6.04K Low: $6.04K High: $6.04K avg. -53.74% | Avg: $3.02K Low: $3.02K High: $3.02K avg. -50% | |
Net Income
% change YoY
| $-5.46M N/A | $-7.65M -40.21% | $-7.07M 7.53% | Avg: $-636 Low: $-636 High: $-636 avg. 99.99% | Avg: $-715 Low: $-715 High: $-715 avg. -12.42% | Avg: $-715 Low: $-715 High: $-715 avg. 0% | |
EBITDA
% change YoY
| $-6.78M N/A | $-8.75M -29.03% | $-7.16M 18.20% | Avg: $-13.05K Low: $-13.05K High: $-13.05K avg. 99.81% | Avg: $-6.04K Low: $-6.04K High: $-6.04K avg. 53.74% | Avg: $-3.02K Low: $-3.02K High: $-3.02K avg. 50% | |
EPS
% change YoY
| -$542.31 N/A | -$619.72 -14.27% | -$224.13 63.83% | Avg: -$0 Low: -$0 High: -$0 avg. 99.99% | Avg: -$0 Low: -$0 High: -$0 avg. -12.52% | Avg: -$0 Low: -$0 High: -$0 avg. 0% | |
Operating Expenses
% change YoY
| $1.98M N/A | $4.05M 104.02% | $4.32M 6.81% | Avg: $113.93K Low: $113.93K High: $113.93K avg. -97.36% | Avg: $52.69K Low: $52.69K High: $52.69K avg. -53.74% | Avg: $26.34K Low: $26.34K High: $26.34K avg. -50.00% | |
FAQ
What is Biodexa Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 29.18% in 2025-2027.
We have gathered data from N/A analysts. Their low estimate is -636, average is -636 and high is -636.
What is Biodexa Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of -66.77% in 2025-2027.
We have gathered data from N/A analysts. Their low revenue estimate is $13.05K, average is $13.05K and high is $13.05K.
What is Biodexa Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 29.15% in 2025-2027.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$0, average is -$0 and high is $-0.00.